Category: NIH

Parent announcements are broad funding opportunity announcements allowing applicants to submit investigator-initiated applications for specific activity codes. They are open for up to 3 years and use standard due dates.

Not all NIH Institutes and Centers participate on all parent announcements. Before submitting your application, make sure the NIH Institute or Center that might be interested in your research is listed as a participating organization in the announcement.

Please note that R01 applications have three options:

PA-19-091- NIH Research Project Grant (Parent R01 Basic Experimental Studies with Humans Required)

PA-19-055- Research Project Grant (Parent R01 Clinical Trial Required)

PA-19-056- Research Project Grant (Parent R01 Clinical Trial Not Allowed)

this link will take you to all the (R) Research Announcements

https://grants.nih.gov/grants/guide/parent_announcements.htm

 

 

NIH recently announced changes impacting grant application submissions for due dates on or after January 25,2019.

The following link will take you to all the changes that affect R15 applications, Fellowships  etc.

Reminder of Policy Changes

 

 

 

 

 

NIH have issued FORMS E for applications due after January 25^th 2018.  One major change that we want to highlight is the importance of identifying at the outset if your study is a clinical trial, as this now impacts which funding opportunity you select.

Please see https://grants.nih.gov/grants/guide/parent_announcements.htm for the list of NIH parent announcements for the new FORMS-E packages. Note that Parent announcements are now split by Clinical Trial Required, and Clinical Trial Not Allowed.  For example, the R01 parent solicitation has changed from 16-160 to 18-484 (clinical trial not allowed) and 18-345 (clinical trial required).

If you need help in determining if your proposal is a clinical trial, please see https://grants.nih.gov/ct-decision/index.htm which brings you through 4 questions to help you decide.  We found the case studies https://grants.nih.gov/policy/clinical-trials/case-studies.htm particularly useful.

Note that Cayuse have implemented these changes so there are new screens to reflect this.  Give yourself plenty of time during proposal preparation to familiarize yourself with what is now required in these sections.

The National Institutes of Health (NIH) has instituted new requirements for studies involving clinical trials and human subjects, as well as new forms that go into effect for NIH applications with deadlines on or after January 25, 2018.  The attached PDF file outlines the new changes and contains helpful links to the NIH policies. Please contact your OSP representative with any questions.

 

NIH_formsE

PHS Assignment Request Form

 

Use the optional PHS Assignment Request Form to list expertise needed to review your application, exclude reviewers, and request an institute assignment.

Here’s why you should use the optional PHS Assignment Request Form:

• Having your application assigned to an institute that is enthusiastic about your research may improve your chances of funding.
• We advise you to request a study section after carefully researching groups that are likely to be scientifically appropriate for your application. For investigator-initiated R01, R21, and R03 applications, we also advise you to request assignment to the most appropriate study section of reviewers.

Taking the time to make this request ensures the best match

In the absence of a request from you, NIH’s Center for Scientific Review (CSR) will assign your application to an institute and study section. CSR bases assignments on its referral criteria, relying on referral staff and knowledge-based technologies to decide.

NIH saves the form separately, so you won’t see it included in your application image after you apply. Your peer reviewers won’t see it, either.

• List up to five areas of expertise needed to understand and review your application
  • Completing this section is a good idea even if you decide not to use the other parts of the form.
  • Highlight disciplines involved, particularly if multidisciplinary, to help the Center for Scientific Review (CSR) assign your application and to ensure the appropriate expertise on the panel.
• Exclude reviewers. NIH policy allows you to list people who should not review your application, though your scientific review officer makes the call.
• Request assignment from CSR to a study section and Institute.

The form includes instructions which you can preview in the Sample PHS Assignment Request Form(link is external)pdf.

See the attached data table that identifies the success rates by Institute/Center:

NIHdata2016 (2) – Copy

 

 

NIH have issued interim guidance on salary limits for NIH grants and cooperative agreements. The direct salary limitation follows Executive Level II of the Federal Executive pay scale, which was previously set at $185,100, and increased to $187,000 effective January 8, 2017. This means that for awards issued in previous years that were restricted to Executive Level II, including competing awards already issued in fiscal year 2017, grantees may rebudget to accommodate the current Executive Level II salary level as long as:

1. adequate funds are available in active awards; and
2. the salary cap increase is consistent with the institutional base salary.

However, no additional funds will be provided to these grant awards.

Note that we provide the Ruth L. Kirschstein National Research Service Award (NRSA) postdoctoral stipend levels and tuition/fees for FY 2017 in NOT-OD-17-003. Until further notice, the NRSA undergraduate and predoctoral stipends and tuition/fees will remain at the levels announced in NOT-OD-16-062.